Arcturus Therapeutics (ARCT) prices offering of 3.2M shares of its common stock at $53.00

Arcturus Therapeutics prices offering of 3,264,151 shares of its common stock at $53.00 per share
The company intends to use the net proceeds of the offering to develop, test, and manufacture the company's LUNAR-COV19 vaccine candidate and to continue clinical development of LUNAR-OTC; to advance the company's LUNAR-CF, LUNAR-CV, and LUNAR-FLU preclinical programs into clinical development; to fund early research and development of novel and proprietary RNA medicines; and for general corporate and working capital purposes.

** charts before  **